# A Six-Week Safety Study of an Investigational Ophthalmic Solution

> **NCT01698814** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 518 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** AL-4943A Ophthalmic Solution
- **DRUG:** AL-4943A Ophthalmic Solution Vehicle

## Key facts

- **NCT ID:** NCT01698814
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 518 (ACTUAL)
- **Last updated:** 2014-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01698814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01698814, "A Six-Week Safety Study of an Investigational Ophthalmic Solution". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01698814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*